PUBLISHER: Grand View Research | PRODUCT CODE: 1122181
PUBLISHER: Grand View Research | PRODUCT CODE: 1122181
U.S. Sex Reassignment Surgery Market Size, Share & Trends Analysis Report By Gender Transition (Male To Female, Female To Male), And Segment Forecasts, 2022 - 2030
U.S. Sex Reassignment Surgery Market Growth & Trends:
The U.S. sex reassignment surgery market size is expected to reach USD 5.0 billion by 2030, expanding at a CAGR of 11.23%, according to a new report by Grand View Research, Inc. Growing public acceptance, rising insurance coverage, and increasing medical insight are expected to boost the demand and enhance access to sex reassignment surgeries in the U.S.
Government bodies are implementing measures to expand access to gender reassignment surgery. Health insurance companies and large corporations are increasingly covering gender-altering operations. According to a poll by Willis Towers Watson, a growing number of firms are implementing transgender medical benefits. A federal prisoner in Wisconsin won her lawsuit for gender transition surgery in December 2020, and in May 2021, the Utah Supreme Court upheld the ability of transgender individuals to amend their sex designation on the birth certificate.
The COVID-19 pandemic has drastically affected the market dynamics, with the cancelation of elective procedures, postponement of opted surgeries, and others. The surgical industry is reviving slowly and new surgery inquiries are increasing for gender affirmation surgeries. Plastic surgeons have seen a drastic decrease in the variety of procedures and services they are allowed to offer during the pandemic. Those who conducted primarily gender affirmation, cosmetic, or other regular elective treatments were affected more than those who performed reconstructive, craniofacial, and hand surgery.
U.S. Sex Reassignment Surgery Market Report Highlights:
- By gender transition, the female-to-male segment held the largest revenue share in 2021. Demand for sex reassignment surgery is increasing due to an increase in the number of people opting for sex-change surgeries and growing awareness and acceptance of the transgender community
- According to the 2020 plastic surgery statistics by the American Society of Plastic Surgeons, breast or chest surgeries are major contributors to the growth of the female-to-male segment
- The increasing number of sex reassignment surgeries is among the major factors driving the growth of the sex reassignment surgery market. Rise is seen among the patients choosing to change their sex from female to male and male to female, which has increased nearly four times ever since the last decade
- The male-to-female transition surgery is expected to witness the fastest growth during the forecast period owing to the high prevalence of gender dysphoria among males
- The companies operating in the market are engaging in new facility launches to strengthen their market presence. For instance, in September 2020, seven hospital facilities within the Mount Sinai Health System have been recognized as national leaders in LGBTQ health care equality by the Human Rights Campaign Foundation's 2020 Healthcare Equality Index (HEI)
Table of Contents
Chapter 1 Report Scope
- 1.1 Market Segmentation
- 1.2 Estimates and Forecast Timeline
Chapter 2 Methodology
- 2.1 Research Methodology
- 2.1.1 Information procurement
- 2.1.2 Purchased Database
- 2.1.3 GVR's Internal Database
- 2.1.4 Secondary Sources
- 2.1.5 Primary Research
- 2.1.6 Details of Primary Research
- 2.2 Information or Data Analysis
- 2.2.1 Data Analysis Models
- 2.3 Market Formulation & Validation
- 2.3.1 Volume Price Analysis
- 2.4 List of Secondary Sources
- 2.5 List of Abbreviations
Chapter 3 Research Objectives
- 3.1 Objective - 1
- 3.2 Objective - 2
- 3.3 Objective - 3
Chapter 4 Executive Summary
- 4.1 Market Outlook
- 4.2 Segment Outlook
- 4.2.1 Gender Transition
- 4.3 Competitive Insights
Chapter 5 U.S. Sex Reassignment Surgery Market - Industry Outlook
- 5.1 Market Lineage Outlook
- 5.1.1 Parent market outlook
- 5.2 Market Dynamics
- 5.2.1 Market driver analysis
- 5.2.1.1 Increasing prevalence of gender dysphoria
- 5.2.1.2 Improving reimbursement scenario and government aids
- 5.2.1.3 Increasing public awareness about transgender surgeries
- 5.2.2 Market restraint analysis
- 5.2.2.1 High cost of procedures
- 5.2.2.2 Risks associated with surgical procedures
- 5.2.1 Market driver analysis
- 5.3 Business Environment Analysis Tools
- 5.3.1 U.S. Sex Reassignment Surgery - Porter's Five Forces Analysis
- 5.3.1.1 Bargaining power of suppliers
- 5.3.1.2 Competitive rivalry
- 5.3.1.3 Bargaining power of buyers
- 5.3.1.4 Threat of new entrants
- 5.3.1.5 Threat of substitutes
- 5.3.2 U.S. Sex Reassignment Surgery- PEStEL Analysis
- 5.3.2.1 Political and legal
- 5.3.2.2 Economic & Technological
- 5.3.2.3 social
- 5.3.1 U.S. Sex Reassignment Surgery - Porter's Five Forces Analysis
- 5.4 Reimbursement Scenario
- 5.5 Penetration & Growth Prospect Mapping
- 5.6 Impact of COVID-19: Qualitative Analysis
Chapter 6 U.S. Sex Reassignment Surgery Market: Gender Transition Analysis
- 6.1 Gender Transition Movement Share Analysis, 2021 & 2030
- 6.2 Gender Transition Segment Dashboard
- 6.2.1 Female to Male
- 6.2.1.1 Female to male transition surgery market, 2017 - 2030 (USD Million)
- 6.2.2 Male to Female
- 6.2.2.1 Male to female transition surgery market, 2017 - 2030 (USD Million)
- 6.2.1 Female to Male
Chapter 7 Competitive Analysis
- 7.1 Recent Developments & Impact Analysis, by Key Market Participants
- 7.2 Competition Categorization
- 7.3 Company Market Position Analysis
- 7.4 Company Profiles
- 7.4.1 The Mount Sinai Health System
- 7.4.1.1 Company overview
- 7.4.1.2 Financial performance
- 7.4.1.3 Service benchmarking
- 7.4.1.4 Strategic initiatives
- 7.4.2 Transgender Surgery Institute of Southern California
- 7.4.2.1 Company overview
- 7.4.2.2 Service benchmarking
- 7.4.3 Cedars Sinai
- 7.4.3.1 Company overview
- 7.4.3.2 Financial performance
- 7.4.3.3 Service benchmarking
- 7.4.3.4 Strategic initiatives
- 7.4.4 Moein Surgical Arts
- 7.4.4.1 Company overview
- 7.4.4.2 Service benchmarking
- 7.4.5 Boston Medical Center
- 7.4.5.1 Company overview
- 7.4.5.2 Financial performance
- 7.4.5.3 Service benchmarking
- 7.4.6 Cleveland Clinic
- 7.4.6.1 Company overview
- 7.4.6.2 Financial performance
- 7.4.6.3 Service benchmarking
- 7.4.7 CNY Cosmetic & Reconstructive Surgery
- 7.4.7.1 Company overview
- 7.4.7.2 Financial performance
- 7.4.7.3 Service benchmarking
- 7.4.8 Plastic Surgery Group Rochester
- 7.4.8.1 Company overview
- 7.4.8.2 Service benchmarking
- 7.4.9 The University of Michigan Health System
- 7.4.9.1 Company overview
- 7.4.9.2 Financial performance
- 7.4.9.3 Service benchmarking
- 7.4.9.4 Strategic initiatives
- 7.4.10 The Johns Hopkins University
- 7.4.10.1 Company overview
- 7.4.10.2 Financial performance
- 7.4.10.3 Service benchmarking
- 7.4.10.4 Strategic initiatives
- 7.4.1 The Mount Sinai Health System
List of Tables
- TABLE 1 U.S. Sex Reassignment Surgery Market, 2017 - 2030 (USD Million)
- TABLE 2 U.S. Sex Reassignment Surgery Market, by Gender Transition, 2017 - 2030 (USD Million)
- TABLE 3 List of secondary sources
- TABLE 4 List of abbreviations
- TABLE 5 SRS surgeries and associated risks
List of Figures
- Fig. 1 U.S. sex reassignment surgery market segmentation
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value-chain-based sizing & forecasting
- Fig. 7 QFD modeling for market share assessment
- Fig. 8 Market formulation & validation
- Fig. 9 Market outlook, 2021 (USD Billion)
- Fig. 10 U.S. sex reassignment surgery market trends & outlook
- Fig. 11 Market driver relevance analysis (Current & future impact)
- Fig. 12 Market restraint relevance analysis (Current & future impact)
- Fig. 13 Penetration & growth prospect mapping
- Fig. 14 U.S. sex reassignment surgery market: Gender transition movement share analysis, (USD Million)
- Fig. 15 U.S sex reassignment surgery market: Gender transition segment dashboard
- Fig. 16 Female to male transition surgery market, 2017 - 2030 (USD Million)
- Fig. 17 Male to female transition surgery market, 2017 - 2030 (USD Million)
- Fig. 18 Impact analysis by key market participants
- Fig. 19 Competition categorization
- Fig. 20 Company market position analysis
